"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to SAVA. [ FAQ on what and how to ask] For non-SAVA questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Richard Jon Barry
Headquarter: 6801 N. Capital of Texas Highway, Suite 300 Building 1, Austin, TX, United States, 78731
Industry: Biotechnology, Investment Track: gene therapy - small, Employees: 30
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
My Watchlist
